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The article by Juarez-Garcia et al. on the costs of
epilepsy misdiagnosis in England and Wales1 makes
interesting reading. The need for comprehensive
epilepsy services to minimise misdiagnosis of epi-
lepsy, and reduce its associated costs is not in doubt.
The terminology used by the authors and some the
assumptions made, however, need clarification.
The estimated prevalence of epilepsy in England
and Wales (7.7/1000) and a misdiagnosis rate of 23%
were used to estimate that 92,000 people were
‘‘misdiagnosed’’ with epilepsy in 2002. It is not clear
why prevalence figures were used, given that most
misdiagnosis estimations are based on consecutive
referrals (first attendance rate as surrogate for
incidence) to specialist clinics-highly selected
cohorts in any case, not representative of the wider
population of people suspected to have epilepsy.
Furthermore, assumptions about costs at time of
diagnosis or misdiagnosis (incident cases) and later
in disease course (prevalent cases) differ consider-
ably and using one or the other inappropriately
introduces considerable error to any overall cost
estimate.
The number of people misdiagnosed with epi-
lepsy each year is likely to be significantly less than
the annual incidence of epilepsy (approximately
20,000/year in England andWales).2 The prevalence
of inappropriate diagnosis among the general popu-
lation is not known, but may be estimated from
community-based prevalence studies. One such
study in Wrexham, UK, circa 1995—1996 suggested1059-1311/$ — see front matter # 2007 Published by Elsevier Ltd o
doi:10.1016/j.seizure.2007.01.006that at that time there was diagnostic doubt in
about 16% of attendees of an epilepsy clinic,3 which
if representative suggests that in England and Wales
about 65,000 people may have been misdiagnosed
at some point. Temporal trends and geographical
variation on this are unknown. The rate at which
cases with inappropriate diagnoses are revised
(or die) is also unknown.
Overall, the failure to distinguish between the
costs associated with incident and prevalent cases
of inappropriate diagnosis, and over-estimation
of the numbers involved significantly weakens the
claim that total costs ‘‘could reach up to £138
million per year’’. A proper study, using appropriate
methodology to address this issue is warranted.References
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